TGFB1 and glioblastoma: We demonstrate that SB525334 selectively enhances CAR-γδT cell function and antitumour efficacy by alleviating TGF-β-mediated immunosuppression and T-cell exhaustion while promoting immune activation within the GBM microenvironment.